Column Group
San Francisco, CAfiles as Column Group LLC
$88m in 3 US stocks at the end of 30 June 2026. The top 10 are 100.0% of the money. It changed about 1.0% of the portfolio this quarter.
Value
$88m
Stocks
3
Top 10 share
100.0%
Turnover
1.0%
What changed this quarter
New
Bought for the first time this quarter.
None this quarter.
Added
Bought more of a stock they already held.
None this quarter.
Cut
Sold some of their stake.
None this quarter.
Sold out
Sold their entire stake.
None this quarter.
Holdings
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| SurrozenSRZN | 56.5% | $50m | 1,916,950 | Held |
| Oric PharmaceuticalsORIC | 43.5% | $38m | 3,540,777 | Held |
| Revolution MedicinesRVMD | <0.1% | $8,615 | 46 | Held |
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is up 34.1% since 30 June 2025.
Where the money is
Health care100.0%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.